Lesley Bailie1, Maurice B Loughrey2, Helen G Coleman3. 1. Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queens University Belfast, Belfast, Northern Ireland. 2. Department of Pathology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland. 3. Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queens University Belfast, Belfast, Northern Ireland. Electronic address: h.coleman@qub.ac.uk.
Abstract
BACKGROUND & AIMS: Certain subsets of colorectal serrated polyps (SP) have malignant potential. We performed a systematic review and meta-analysis to investigate the association between modifiable lifestyle factors and risk for SPs. METHODS: We conducted a systematic search of Medline, Embase, and Web of Science for observational or interventional studies that contained the terms risk or risk factor, and serrated or hyperplastic, and polyps or adenomas, and colorectal (or synonymous terms), published by March 2016. Titles and abstracts of identified articles were independently reviewed by at least 2 reviewers. Adjusted relative risk (RR) and 95% confidence interval (CI) were combined using random effects meta-analyses to assess the risk of SP, when possible. RESULTS: We identified 43 studies of SP risk associated with 7 different lifestyle factors: smoking, alcohol, body fatness, diet, physical activity, medication, and hormone-replacement therapy. When we compared the highest and lowest categories of exposure, factors we found to significantly increase risk for SP included tobacco smoking (RR, 2.47; 95% CI, 2.12-2.87), alcohol intake (RR, 1.33; 95% CI, 1.17-1.52), body mass index (RR, 1.40; 95% CI, 1.22-1.61), and high intake of fat or meat. Direct associations for smoking and alcohol, but not body fat, tended to be stronger for sessile serrated adenomas/polyps than hyperplastic polyps. In contrast, factors we found to significantly decrease risks for SP included use of nonsteroidal anti-inflammatory drugs (RR, 0.77; 95% CI, 0.65-0.92) or aspirin (RR, 0.81; 95% CI, 0.67-0.99), as well as high intake of folate, calcium, or fiber. No significant associations were detected between SP risk and physical activity or hormone replacement therapy. CONCLUSIONS: Several lifestyle factors, most notably smoking and alcohol, are associated with SP risk. These findings enhance our understanding of mechanisms of SP development and indicate that risk of serrated pathway colorectal neoplasms could be reduced with lifestyle changes.
BACKGROUND & AIMS: Certain subsets of colorectal serrated polyps (SP) have malignant potential. We performed a systematic review and meta-analysis to investigate the association between modifiable lifestyle factors and risk for SPs. METHODS: We conducted a systematic search of Medline, Embase, and Web of Science for observational or interventional studies that contained the terms risk or risk factor, and serrated or hyperplastic, and polyps or adenomas, and colorectal (or synonymous terms), published by March 2016. Titles and abstracts of identified articles were independently reviewed by at least 2 reviewers. Adjusted relative risk (RR) and 95% confidence interval (CI) were combined using random effects meta-analyses to assess the risk of SP, when possible. RESULTS: We identified 43 studies of SP risk associated with 7 different lifestyle factors: smoking, alcohol, body fatness, diet, physical activity, medication, and hormone-replacement therapy. When we compared the highest and lowest categories of exposure, factors we found to significantly increase risk for SP included tobacco smoking (RR, 2.47; 95% CI, 2.12-2.87), alcohol intake (RR, 1.33; 95% CI, 1.17-1.52), body mass index (RR, 1.40; 95% CI, 1.22-1.61), and high intake of fat or meat. Direct associations for smoking and alcohol, but not body fat, tended to be stronger for sessile serrated adenomas/polyps than hyperplastic polyps. In contrast, factors we found to significantly decrease risks for SP included use of nonsteroidal anti-inflammatory drugs (RR, 0.77; 95% CI, 0.65-0.92) or aspirin (RR, 0.81; 95% CI, 0.67-0.99), as well as high intake of folate, calcium, or fiber. No significant associations were detected between SP risk and physical activity or hormone replacement therapy. CONCLUSIONS: Several lifestyle factors, most notably smoking and alcohol, are associated with SP risk. These findings enhance our understanding of mechanisms of SP development and indicate that risk of serrated pathway colorectal neoplasms could be reduced with lifestyle changes.
Authors: Xiaosheng He; Kana Wu; Shuji Ogino; Edward L Giovannucci; Andrew T Chan; Mingyang Song Journal: Gastroenterology Date: 2018-04-24 Impact factor: 22.682
Authors: Seth D Crockett; Elizabeth L Barry; Leila A Mott; Dennis J Ahnen; Douglas J Robertson; Joseph C Anderson; Kristen Wallace; Carol A Burke; Robert S Bresalier; Jane C Figueiredo; Dale C Snover; John A Baron Journal: Gut Date: 2018-03-01 Impact factor: 23.059
Authors: Akihisa Hidaka; Tabitha A Harrison; Yin Cao; Lori C Sakoda; Richard Barfield; Marios Giannakis; Mingyang Song; Amanda I Phipps; Jane C Figueiredo; Syed H Zaidi; Amanda E Toland; Efrat L Amitay; Sonja I Berndt; Ivan Borozan; Andrew T Chan; Steven Gallinger; Marc J Gunter; Mark A Guinter; Sophia Harlid; Heather Hampel; Mark A Jenkins; Yi Lin; Victor Moreno; Polly A Newcomb; Reiko Nishihara; Shuji Ogino; Mireia Obón-Santacana; Patrick S Parfrey; John D Potter; Martha L Slattery; Robert S Steinfelder; Caroline Y Um; Xiaoliang Wang; Michael O Woods; Bethany Van Guelpen; Stephen N Thibodeau; Michael Hoffmeister; Wei Sun; Li Hsu; Daniel D Buchanan; Peter T Campbell; Ulrike Peters Journal: Cancer Res Date: 2020-08-14 Impact factor: 12.701
Authors: Joseph C Anderson; Audrey H Calderwood; Brock C Christensen; Christina M Robinson; Christopher I Amos; Lynn Butterly Journal: Am J Gastroenterol Date: 2018-11-01 Impact factor: 10.864
Authors: Mingyang Song; I-Min Lee; JoAnn E Manson; Julie E Buring; Rimma Dushkes; David Gordon; Joseph Walter; Kana Wu; Andrew T Chan; Shuji Ogino; Charles S Fuchs; Jeffrey A Meyerhardt; Edward L Giovannucci Journal: Clin Gastroenterol Hepatol Date: 2020-02-13 Impact factor: 11.382